TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $29.3K2014: $19.5K2015: $20.0K2016: $34.9K2017: $23.3K2018: $564.4K2019: $262.0K2020: $63.0K2021: $113.0K2022: $95.0K$95.0K
2013Capital Expenditures (USD)2022
Fiscal YearCapital ExpendituresChange YoY
2022$95.0K-15.9%
2021$113.0K+79.4%
2020$63.0K-76.0%
2019$262.0K-53.6%
2018$564.4K+2319.8%
2017$23.3K-33.1%
2016$34.9K+74.6%
2015$20.0K+2.5%
2014$19.5K-33.4%
2013$29.3K—